Cytrx reported 6.56M in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Bioline Rx BLRX:US $ 74.77M 6.62M
Brainstorm Cell Therapeutics BCLI:US $ 25.79M 3.49M
Celldex Therapeutics CLDX:US $ 402.96M 21.08M
Curis CRIS:US $ 128.83M 11.9M
Cytrx CYTR:US 6.56M 2.16M
Glaxosmithkline GSK:US $ 89045M 644M
Karyopharm Therapeutics KPTI:US $ 256.48M 37.56M
Northwest Biotherapeutics NWBO:US 30.66M 9.5M
Novartis NVS:US $ 122910M 2308M
Seattle Genetics SGEN:US $ 3630.34M 13.65M
Takeda 4502:JP Y 14065426M 887408M